Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2024

Nu Skin's Q1 Earnings Call: Mixed Performance, Strategic Initiatives for Growth

Nu Skin's Q1 performance reflected a mixed picture, with challenges in certain regions and positive results in others. The company's strategic initiatives, such as the introduction of TRMe and plans for revenue diversification, demonstrate a proactive approach to addressing market dynamics and driving future growth.

Nu Skin Enterprises reports Q2 growth in China, invests strategically

Nu Skin Enterprises reported strong performance in Mainland China, while facing challenges in other markets. The company's strategic investments and upcoming initiatives indicate a focus on innovation and growth. With a projected revenue of $2.0 billion to $2.08 billion for full year 2023, Nu Skin Enterprises is poised for continued expansion and market development.

Nu Skin Enterprises reports mixed Q3 results, focuses on personalized products and Rhyz segment for future growth

Nu Skin Enterprises reported mixed Q3 results, with revenue at $499 million and non-GAAP earnings per share of $0.56. The company faced challenges in Mainland China and the Americas but is strategically focusing on personalized products and the Rhyz segment for future growth.

Nu Skin surpasses Q4 revenue targets, eyes growth in new markets

Nu Skin Enterprises delivered strong financial results in Q4 2023, surpassing revenue expectations and outlining ambitious growth plans for 2024. While facing challenges in certain regions, the company remains focused on innovation, market expansion, and enhancing customer engagement to drive future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Nu Skin (NUS) Up 11.9% Since Last Earnings Report: Can It Continue?

Nu Skin (NUS) has been seeing improved trends in Mainland China as coronavirus-induced restrictions are being lifted in the region.

Here's Why Nu Skin (NUS) Stock is Up More Than 40% in a Month

As of late, it has definitely been a great time to be an investor in Nu Skin Enterprises

Nu Skin Enterprises' Shares March Higher, Can It Continue?

NUS vs. PORBF: Which Stock Is the Better Value Option?

Coty

Estee Lauder

Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes

Both Q1 results and 2020 guidance came in significantly higher than analyst estimates.

Why Nu Skin Enterprises Blasted Nearly 30% Higher on Thursday

Why Nu Skin Enterprises Blasted Nearly 30% Higher on Thursday (NUS)

Nu Skin's (NUS) first-quarter 2020 results reflect lower earnings and sales. Foreign currency headwinds and reduced sales leaders in Mainland China hurt results.

Nu Skin's (NUS) Q1 Earnings Beat Estimates, Decline Y/Y

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q1 2020 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 50.00% and 6.90%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings and Revenue Estimates

Multi-level marketing company Nu Skin Enterprises Inc. NUS, +0.36% shares rose nearly 8% in the extended session Wednesday, after the company beat earnings and revenue expectations.

Nu Skin stock rises after earnings beat

Impacts from foreign currency headwinds are likely to get reflected on Nu Skin's (NUS) first-quarter 2020 results. Also, restrictions on travel amid coronavirus are a concern.

Here's How Nu Skin (NUS) is Placed Ahead of Q1 Earnings

AbbVie

Bunge Global SA

Chevron

DXC Technology

Patterson Companies

Steep market declines in 2020 have not only been brutal on returns; they've also presented income investors with a conundrum.

8 Safe High-Yield Dividend Stocks Offering 5% or More

Why Is Nu Skin (NUS) Down 37.4% Since Last Earnings Report?

Nu Skin (NUS) anticipates sales in Mainland China to decline 20-25% in 2020. The company puts meetings on hold in the region due to the coronavirus outbreak.

Will Nu Skin Mainland China Woes Worsen Due to Coronavirus?

In trading on Thursday, shares of NU Skin Enterprises, Inc. (NYSE:NUS) were yielding above the 6% mark based on its quarterly dividend (annualized to $1.5), with the stock changing hands as low as $24.34 on the day.

NU Skin Enterprises Breaks Above 6% Yield Territory

Inter Parfums

Coronavirus-led worries weigh on the guidance of these cosmetic stocks due to reduced global travel and sluggish traffic.

Coronavirus Steals Glitter Off These 3 Cosmetic Stocks

The coronavirus outbreak in China is badly hurting the maker of personal care products.

Why Nu Skin Enterprises Stock Fell Today

Nu Skin's (NUS) fourth-quarter 2019 results reflect lower earnings and sales. Further, management expects the coronavirus outbreak to hurt Mainland China sales in 2020.

Nu Skin's (NUS) Q4 Earnings Meet Estimates, Down Year on Year

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q4 2019 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Q4 Earnings Match Estimates

Nu Skin Enterprises Inc. NUS, +3.38% shares dropped in the extended session Wednesday after the maker of supplements and personal care products blamed its disappointing outlook on sales in China due to the COVAD-19 coronavirus.

Nu Skin stock drops more than 10% on China profit warning

Impacts from foreign currency headwinds are likely to get reflected in Nu Skin's (NUS) fourth-quarter 2019 results. However, the company is on track with product launches and programs to bolster sales leaders.

Here's How Nu Skin (NUS) is Placed Ahead of Q4 Earnings

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Nu Skin Enterprises (NUS) Q4 Earnings Expected to Decline

If You're OK With Taking On Regulatory Risks, Nu Skin Might Be Right For You

News for Nu Skin Enterprises Stock (NUS)